Variant report
Variant | esv3405992 |
---|---|
Chromosome Location | chr22:30849377-30852325 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr22:30841425..30844218-chr22:30849960..30852881,2 | MCF-7 | breast: | |
2 | chr22:30848250..30850657-chr22:30859446..30861041,2 | K562 | blood: | |
3 | chr22:30839545..30842321-chr22:30849222..30852849,3 | K562 | blood: | |
4 | chr22:30839961..30842016-chr22:30851349..30853503,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs537760714 | chr22:30849423-30849424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs574019592 | chr22:30849435-30849436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs5749099 | chr22:30849451-30849452 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs570990754 | chr22:30849460-30849461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs376728267 | chr22:30849469-30849470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs535209662 | chr22:30849500-30849501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs553238226 | chr22:30849525-30849526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs574879012 | chr22:30849591-30849592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs371317499 | chr22:30849642-30849643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs541887731 | chr22:30849686-30849687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs56174416 | chr22:30849689-30849690 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
12 | rs141123004 | chr22:30849690-30849691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs545727544 | chr22:30849696-30849697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs202162224 | chr22:30849755-30849756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs577608925 | chr22:30849792-30849793 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs73390297 | chr22:30849801-30849802 | Weak transcription ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs528323926 | chr22:30849814-30849815 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
18 | rs75645541 | chr22:30849836-30849837 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
19 | rs561694627 | chr22:30849889-30849890 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
20 | rs187095027 | chr22:30849934-30849935 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
21 | rs377602711 | chr22:30849953-30849954 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
22 | rs550664827 | chr22:30849956-30849957 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
23 | rs118000788 | chr22:30849974-30849975 | Weak transcription ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
24 | rs146545864 | chr22:30850035-30850036 | Enhancers ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs149145062 | chr22:30850122-30850123 | Enhancers ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs571121457 | chr22:30850163-30850164 | Enhancers ZNF genes & repeats Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs534959355 | chr22:30850239-30850240 | Enhancers Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs553547680 | chr22:30850271-30850272 | Enhancers Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs568534296 | chr22:30850277-30850278 | Enhancers Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs535583450 | chr22:30850287-30850288 | Enhancers Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs557021537 | chr22:30850307-30850308 | Enhancers Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs573479319 | chr22:30850319-30850320 | Enhancers Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575277135 | chr22:30850338-30850339 | Enhancers Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs12627940 | chr22:30850371-30850372 | Enhancers Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs557823667 | chr22:30850386-30850387 | Enhancers Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs12627888 | chr22:30850395-30850396 | Enhancers Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs114962488 | chr22:30850435-30850436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs561938886 | chr22:30850443-30850444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs148328445 | chr22:30850460-30850461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs13054370 | chr22:30850462-30850463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs200557153 | chr22:30850486-30850487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs113775490 | chr22:30850498-30850499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs28483863 | chr22:30850511-30850512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs562560628 | chr22:30850514-30850515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs371975171 | chr22:30850521-30850522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs10677216 | chr22:30850527-30850528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs112583160 | chr22:30850530-30850531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs201278040 | chr22:30850532-30850533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs377711428 | chr22:30850543-30850544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs181084806 | chr22:30850549-30850550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Velocardiofacial syndrome | 20111667 | CNVD |
Medulloblastoma | 21979893 | CNVD |
sporadic solitary meningiomas | 19589153 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Congenital heart defect | 22511896 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Seminomas | 18059402 | CNVD |
Cancer | 16751803 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Metachromatic leukodystrophy | 18421352 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Breast cancer | 21858162 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Ovarian cancer | 22174824 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Lung cancer | 18438408 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 21183584 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Schizophrenia | 19521646 | CNVD |
Schizophrenia | 18990708 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Autism | 17322880 | CNVD |
Breast cancer | 20409316 | CNVD |
Neurofibromatosis type 2 | 19566914 | CNVD |
Autism | 19384346 | CNVD |
Myelofibrosis | 22110671 | CNVD |
muscular dystrophy type 1D | 21248746 | CNVD |
Leukoplakia | 24403051 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Autism | 22495309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr22:30832000-30850000 | Weak transcription | Right Atrium | heart |
2 | chr22:30832200-30852400 | Weak transcription | Spleen | Spleen |
3 | chr22:30841800-30850000 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr22:30847000-30849800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr22:30847400-30854200 | Weak transcription | Gastric | stomach |
6 | chr22:30848000-30850000 | Weak transcription | Fetal Intestine Large | intestine |
7 | chr22:30848200-30850000 | Weak transcription | Fetal Intestine Small | intestine |
8 | chr22:30849800-30850000 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr22:30850000-30850200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
10 | chr22:30850000-30850400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
11 | chr22:30850000-30850400 | ZNF genes & repeats | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr22:30850000-30850400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
13 | chr22:30850000-30850400 | Enhancers | Fetal Intestine Large | intestine |
14 | chr22:30850200-30850400 | Flanking Active TSS | H1 Derived Mesenchymal Stem Cells | ES cell derived |
15 | chr22:30850200-30850400 | Bivalent Enhancer | IMR90 fetal lung fibroblasts Cell Line | lung |
16 | chr22:30850200-30850400 | Enhancers | Fetal Intestine Small | intestine |
17 | chr22:30850400-30851000 | Weak transcription | Right Atrium | heart |
18 | chr22:30850400-30851400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
19 | chr22:30850400-30854000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
20 | chr22:30851400-30851800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
21 | chr22:30851800-30852000 | Bivalent/Poised TSS | Foreskin Fibroblast Primary Cells skin02 | Skin |